Celgene Corporation (NASDAQ: CELG) and Juno Therapeutics, Inc. (NASDAQ: JUNO) today announced the signing of a definitive merger agreement in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hot Corp. News Hot M&A Mergers and Acquisitions

Notable Call Buying Activity Continues in Celgene (CELG) Following Reported Acquisition of Juno Therapeutics (JUNO) -Susquehanna January 23, 2018 1:41 PM Celgene (CELG) PT Lowered to $117 at BofA/Merrill Lynch Following Juno (JUNO) AcquisitionJanuary 22, 2018 11:12 AM Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular ImmunotherapyJanuary 22, 2018 6:30 AM